Latest filing published 14 Feb 2025 for Enanta Pharmaceuticals INC, €18k.
Filing timeline
BuySaleInsider track record
Paul J. Mellett: trading record in brief
Paul J. Mellett discloses dealings in Enanta Pharmaceuticals Inc to SEC (Form 4). Over a trading history stretching from 11 July 2013 to 12 February 2025, the count stands at 91 filings.
No open-market purchase appears, only 44 sales worth €7.9M. The rest of the record consists of 30 share grants and 17 option exercises.
The latest filing, published on 14 February 2025, reports a share grant of €18k in Enanta Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Paul J. Mellett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,326 shares@ US$5.590.3% of flowCommon StockSEC:0001062993-25-002553:1
- 7,500 shares0Common StockSEC:0001062993-25-002553:0
- 2,591 shares@ US$8.063.1% of flowCommon StockSEC:0001062993-24-020378:0
- 1,595 shares@ US$8.602.0% of flowCommon StockSEC:0001062993-24-019980:0
- 973 shares@ US$12.410.2% of flowCommon StockSEC:0001062993-24-003226:1
- 3,320 shares0Common StockSEC:0001062993-24-003226:0
- 2,412 shares@ US$9.633.4% of flowCommon StockSEC:0001062993-23-022047:0
- 1,595 shares@ US$9.492.2% of flowCommon StockSEC:0001062993-23-021983:0
- 100 shares@ US$43.960.1% of flowCommon StockSEC:0001062993-23-007223:1
- 10,340 shares@ US$44.438.1% of flowCommon StockSEC:0001062993-23-007223:2
- 10,440 shares@ US$14.0021.5% of flowCommon StockSEC:0001062993-23-007223:0
- 6,904 shares@ US$52.776.5% of flowCommon StockSEC:0001062993-23-003713:2
- 11,747 shares0Common StockSEC:0001062993-23-003713:1
- 9,250 shares0Common StockSEC:0001062993-23-003713:0
- 800 shares@ US$54.410.8% of flowCommon StockSEC:0001062993-23-002936:1
- 4,200 shares@ US$53.6433.1% of flowCommon StockSEC:0001062993-23-002936:0
- 2,812 shares@ US$14.185.9% of flowCommon StockSEC:0001062993-23-000800:0
- 4,148 shares@ US$14.188.8% of flowCommon StockSEC:0001062993-22-024175:0
- 1,055 shares@ US$44.337.1% of flowCommon StockSEC:0001062993-22-023361:0
- 21,000 shares0Common StockSEC:0001062993-22-022841:0
- 3,480 shares@ US$11.770.0100% mcap6.1% of flowCommon StockSEC:0001062993-22-015258:0
- 958 shares@ US$62.491.0% of flowCommon StockSEC:0001062993-22-004512:2
- 2,419 shares0Common StockSEC:0001062993-22-004512:1
- 615 shares0Common StockSEC:0001062993-22-004512:0
- 557 shares@ US$87.686.8% of flowCommon StockSEC:0001062993-21-012199:0
25 of 90 declarations
